Stéphane Fourcade1,Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), Gran Via 199, L’Hospitalet de Llobregat, Barcelona, Spain2CIBERER U759, Center for Biomedical Research on Rare Diseases, Valencia, Spain, Tiago F. Outeiro3,Institute of Neuroscience, The Medical School, Newcastle University, Framlington Place, Newcastle Upon Tyne NE2 4HH, UK4,Department of Experimental Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB), Center for Biostructural Imaging of Neurodegeneration, University Medical Center Göttingen, Göttingen 37073, Germany5Max Planck Institute for Experimental Medicine, Göttingen, Germany, Aurora Pujol1,Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), Gran Via 199, L’Hospitalet de Llobregat, Barcelona, Spain2,CIBERER U759, Center for Biomedical Research on Rare Diseases, Valencia, Spain6Catalan Institution of Research and Advanced Studies (ICREA), Barcelona, Spain
- 1Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), Gran Via 199, L’Hospitalet de Llobregat, Barcelona, Spain
- 2CIBERER U759, Center for Biomedical Research on Rare Diseases, Valencia, Spain
- 3Institute of Neuroscience, The Medical School, Newcastle University, Framlington Place, Newcastle Upon Tyne NE2 4HH, UK
- 4Department of Experimental Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB), Center for Biostructural Imaging of Neurodegeneration, University Medical Center Göttingen, Göttingen 37073, Germany
- 5Max Planck Institute for Experimental Medicine, Göttingen, Germany
- 6Catalan Institution of Research and Advanced Studies (ICREA), Barcelona, Spain
